News Release: uniQure Announces Sale of Commercial Manufacturing Facility to Genezen
July 1, 2024 ~ Proposed divestiture streamlines uniQure’s focus and represents an important milestone in its ongoing effort to significantly reduce operating expenses ~ ~ Genezen to manufacture global commercial supply of HEMGENIX® and support uniQure’s pipeline programs as a preferred customer ~ ~ uniQure to reduce cash burn by $40 million per year and […]
